Cargando…

Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection

Introduction Accurate point-of-care testing for SARS-CoV-2 could quickly identify which patients need to be isolated and improve flow for patients being admitted as an emergency to the hospital. We evaluated two diagnostic tests with shorter turnaround times, the Siemens Clinitest Lateral Flow (Siem...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyle, Adrian A, Hardwick, Susie, Warne, Ben, Nwuba, Chukwuneyem Kosisochukwu, Brown, Nicholas, Shaw, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553283/
https://www.ncbi.nlm.nih.gov/pubmed/34725589
http://dx.doi.org/10.7759/cureus.18319
_version_ 1784591545885786112
author Boyle, Adrian A
Hardwick, Susie
Warne, Ben
Nwuba, Chukwuneyem Kosisochukwu
Brown, Nicholas
Shaw, Ashley
author_facet Boyle, Adrian A
Hardwick, Susie
Warne, Ben
Nwuba, Chukwuneyem Kosisochukwu
Brown, Nicholas
Shaw, Ashley
author_sort Boyle, Adrian A
collection PubMed
description Introduction Accurate point-of-care testing for SARS-CoV-2 could quickly identify which patients need to be isolated and improve flow for patients being admitted as an emergency to the hospital. We evaluated two diagnostic tests with shorter turnaround times, the Siemens Clinitest Lateral Flow (Siemens Healthineers AG, Erlangen, Germany) and the Simple AMplification-Based Assay (SAMBA)-2 PCR test against a standard laboratory PCR test. Methods We conducted a prospective diagnostic cohort study in a single English emergency department. Adult participants underwent three swabs: the Siemens Clinitest Lateral Flow Test, the SAMBA-2 and a standard laboratory PCR test. Results A total of 212 participants were recruited. The sensitivity and specificity of the Siemens Clinitest Lateral Flow Test against the laboratory PCR test was 55.6% (95% CI 30.8-78.5) and 100% (95% CI 98.1-100) respectively. The sensitivity and specificity of the SAMBA-2 PCR test against the laboratory PCR test was 60.0% (95% CI 32.3-83.7) and 100% (95% CI 97.9-100) respectively. Conclusion Neither the Siemens Clinitest Lateral Flow Test nor the SAMBA-2 PCR test demonstrated sufficient sensitivity to rule out active SARS-CoV-2 infection. Both tests demonstrated high specificity.
format Online
Article
Text
id pubmed-8553283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85532832021-10-31 Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection Boyle, Adrian A Hardwick, Susie Warne, Ben Nwuba, Chukwuneyem Kosisochukwu Brown, Nicholas Shaw, Ashley Cureus Emergency Medicine Introduction Accurate point-of-care testing for SARS-CoV-2 could quickly identify which patients need to be isolated and improve flow for patients being admitted as an emergency to the hospital. We evaluated two diagnostic tests with shorter turnaround times, the Siemens Clinitest Lateral Flow (Siemens Healthineers AG, Erlangen, Germany) and the Simple AMplification-Based Assay (SAMBA)-2 PCR test against a standard laboratory PCR test. Methods We conducted a prospective diagnostic cohort study in a single English emergency department. Adult participants underwent three swabs: the Siemens Clinitest Lateral Flow Test, the SAMBA-2 and a standard laboratory PCR test. Results A total of 212 participants were recruited. The sensitivity and specificity of the Siemens Clinitest Lateral Flow Test against the laboratory PCR test was 55.6% (95% CI 30.8-78.5) and 100% (95% CI 98.1-100) respectively. The sensitivity and specificity of the SAMBA-2 PCR test against the laboratory PCR test was 60.0% (95% CI 32.3-83.7) and 100% (95% CI 97.9-100) respectively. Conclusion Neither the Siemens Clinitest Lateral Flow Test nor the SAMBA-2 PCR test demonstrated sufficient sensitivity to rule out active SARS-CoV-2 infection. Both tests demonstrated high specificity. Cureus 2021-09-27 /pmc/articles/PMC8553283/ /pubmed/34725589 http://dx.doi.org/10.7759/cureus.18319 Text en Copyright © 2021, Boyle et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Boyle, Adrian A
Hardwick, Susie
Warne, Ben
Nwuba, Chukwuneyem Kosisochukwu
Brown, Nicholas
Shaw, Ashley
Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title_full Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title_fullStr Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title_full_unstemmed Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title_short Evaluating the Sensitivity and Specificity of Siemens Clinitest Lateral Flow Test and the Simple AMplification-Based Assay (SAMBA)-2 PCR Test for SARS-CoV-2 Infection
title_sort evaluating the sensitivity and specificity of siemens clinitest lateral flow test and the simple amplification-based assay (samba)-2 pcr test for sars-cov-2 infection
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553283/
https://www.ncbi.nlm.nih.gov/pubmed/34725589
http://dx.doi.org/10.7759/cureus.18319
work_keys_str_mv AT boyleadriana evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection
AT hardwicksusie evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection
AT warneben evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection
AT nwubachukwuneyemkosisochukwu evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection
AT brownnicholas evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection
AT shawashley evaluatingthesensitivityandspecificityofsiemensclinitestlateralflowtestandthesimpleamplificationbasedassaysamba2pcrtestforsarscov2infection